Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Ganan-Gomez

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
STAR Protocols|October 14, 2022
Isolation, culture, and immunophenotypic analysis of bone marrow HSPCs from patients with myelodysplastic syndromesIrene Ganan-Gomez, Karen Clise-Dwyer, Simona Colla
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2025
Hematopoietic Stem Cell Hierarchies as Novel Biomarkers of Drug Response in Myelodysplastic Syndromes and Acute Myeloid LeukemiaTeresa Ezponda, Ana Aldaz, Ana Alfonso-Pierola, et al.
Bioinformatics (Oxford, England)|September 9, 2022
A machine learning-based method for automatically identifying novel cells in annotating single-cell RNA-seq dataZiyi Li, Yizhuo Wang, Irene Ganan-Gomez, et al.
Scientific Reports|October 15, 2024
Accurate identification of locally aneuploid cells by incorporating cytogenetic information in single cell data analysisZiyi Li, Ruoxing Li, Irene Ganan-Gomez, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
PDE4 Differential Expression Is a Potential Prognostic Factor and Therapeutic Target in Patients With Myelodysplastic Syndrome and Chronic Myelomonocytic LeukemiaAli N Chamseddine, Monica Cabrero, Yue Wei, et al.
Leukemia Research|March 13, 2016
Down-regulation of EZH2 expression in myelodysplastic syndromesMonica Cabrero, Yue Wei, Hui Yang, et al.
Leukemia & Lymphoma|February 11, 2020
LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agentsKelly S Chien, Caleb A Class, Guillermo Montalban-Bravo, et al.
Leukemia & Lymphoma|September 5, 2022
MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemiaYue Wei, Hong Zheng, Pamela Pennington Lockyer, et al.
Blood Advances|October 3, 2018
KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in miceYue Wei, Hong Zheng, Naran Bao, et al.
British Journal of Haematology|June 25, 2015
Downregulation of Protection of Telomeres 1 expression in myelodysplastic syndromes with 7q deletionMonica Cabrero, Yiting Yu, Amit Verma, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
STAR Protocols|October 14, 2022
Isolation, culture, and immunophenotypic analysis of bone marrow HSPCs from patients with myelodysplastic syndromesIrene Ganan-Gomez, Karen Clise-Dwyer, Simona Colla
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2025
Hematopoietic Stem Cell Hierarchies as Novel Biomarkers of Drug Response in Myelodysplastic Syndromes and Acute Myeloid LeukemiaTeresa Ezponda, Ana Aldaz, Ana Alfonso-Pierola, et al.
Bioinformatics (Oxford, England)|September 9, 2022
A machine learning-based method for automatically identifying novel cells in annotating single-cell RNA-seq dataZiyi Li, Yizhuo Wang, Irene Ganan-Gomez, et al.
Scientific Reports|October 15, 2024
Accurate identification of locally aneuploid cells by incorporating cytogenetic information in single cell data analysisZiyi Li, Ruoxing Li, Irene Ganan-Gomez, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
PDE4 Differential Expression Is a Potential Prognostic Factor and Therapeutic Target in Patients With Myelodysplastic Syndrome and Chronic Myelomonocytic LeukemiaAli N Chamseddine, Monica Cabrero, Yue Wei, et al.
Leukemia Research|March 13, 2016
Down-regulation of EZH2 expression in myelodysplastic syndromesMonica Cabrero, Yue Wei, Hui Yang, et al.
Leukemia & Lymphoma|February 11, 2020
LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agentsKelly S Chien, Caleb A Class, Guillermo Montalban-Bravo, et al.
Leukemia & Lymphoma|September 5, 2022
MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemiaYue Wei, Hong Zheng, Pamela Pennington Lockyer, et al.
Blood Advances|October 3, 2018
KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in miceYue Wei, Hong Zheng, Naran Bao, et al.
British Journal of Haematology|June 25, 2015
Downregulation of Protection of Telomeres 1 expression in myelodysplastic syndromes with 7q deletionMonica Cabrero, Yiting Yu, Amit Verma, et al.
Pageof 3